Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 4, 2000

Primary Completion Date

November 7, 2002

Study Completion Date

September 22, 2008

Conditions
Sarcoma
Interventions
DRUG

alvocidib

Flavopiridol 50 mg/m2 IV over 1 hour daily x 3 days every 3 weeks

Trial Locations (61)

55805

St. Mary's/Duluth Clinic Health System, Duluth

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

T1J 1W5

Lethbridge Cancer Clinic, Lethbridge

V5H 4C2

Burnaby Hospital Regional Cancer Centre, Burnaby

V9S 2B7

Nanaimo Cancer Clinic, Nanaimo

V2A 3G6

Penticton Regional Hospital, Penticton

V3V 1Z2

British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey

V5Z 3J5

Prostate Centre at Vancouver General Hospital, Vancouver

V5Z 4E6

BC Cancer Agency, Vancouver

V6Z 1Y6

St. Paul's Hospital - Vancouver, Vancouver

V8V 3N1

Capital Health Region (Endeavor Clinical Research), Victoria

E1C 6ZB

Moncton Hospital, Moncton

E1C 8X3

Doctor Leon Richard Oncology Centre, Moncton

E2L 4L2

Saint John Regional Hospital, Saint John

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

Nova Scotia Cancer Centre, Halifax

L4M 6M2

Royal Victoria Hospital, Barrie, Barrie

L6W 2Z8

William Osler Health Centre, Brampton

P3E 5J1

Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury

L8N 1T8

Hamilton and Disrict Urology Association, Hamilton

N6A 4G5

London Health Sciences Centre, London

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

L3P 7T3

Markham Stouffville Hospital, Markham

L5B 1B8

Trillium Health Centre, Mississauga

L5M 2N1

Credit Valley Hospital, Mississauga

L3Y 2P9

York County Hospital, Newmarket

M2E 1K1

North York General Hospital, Ontario, North York

L6H 3PI

Male Health Centre/CMX Research Inc., Oakville

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 1C4

Ottawa Regional Cancer Centre - General Campus, Ottawa

K9H 7B6

Peterborough Oncology Clinic, Peterborough

M1P 2V5

Scarborough Hospital - General Site, Scarborough Village

L2R 5K3

Hotel Dieu Hospital - St. Catharines, St. Catharines

P7A 7T1

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay

M4C 3E7

Toronto East General Hospital, Toronto

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital - Toronto, Toronto

M5G 1X5

Mount Sinai Hospital - Toronto, Toronto

M5G 2C4

Toronto General Hospital, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

M5S 1B6

Women's College Campus, Sunnybrook and Women's College Health Science Center, Toronto

M6R 1B5

Saint Joseph's Health Centre - Toronto, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

C1A 8T5

Queen Elizabeth Hospital, PEI, Charlottetown

J1H 5N4

Centre Universitaire de Sante de l'Estrie - Site Fleurimont, Fleurimont

J4V 2H1

Hopital Charles Lemoyne, Greenfield Park

J6E 6J2

Centre Hospitalier Regional de Lanaudiere, Joliette

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

H2W 1S6

McGill University Department of Oncology, Montreal

H2W 1T8

Centre Hospitalier de l'Universite' de Montreal, Montreal

H3T 1C5

Hopital Sainte Justine, Montreal

H4J 1C5

Hopital Du Sacre-Coeur de Montreal, Montreal

H9R 4S3

Kells Medical Research Group Inc., Pointe-Claire

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Québec

G1S 4L8

Hopital du Saint-Sacrament, Quebec, Québec

G5L 5T1

Centre Hospitalier Regional de Rimouski, Rimouski

G1V 4G5

L'Hopital Laval, Ste-Foy

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

V7L 2P9

Lions Gate Hospital, North Vancouver

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK